Substantiation for the optimal strategy of risk management in marketing communicative activities of pharmaceutical enterprises based on mathematical model approach
Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 5
Abstract
Aim. To develop a mathematical model of risk analysis and evaluation in the marketing communication activity of pharmaceutical manufacturing enterprises in promoting a new medicine product under limiting and (or) saving investment funds for marketing communications. The obtained results allowed to make reasonable decisions as for choosing the optimal risk management strategy in marketing communication activities of pharmaceutical enterprises. Methods. The implementation of the above tasks predetermined the choice of the following methods: content analysis, logical analysis, grouping and generalization, mathematical model methods, etc. Results. The research resulted into introduction of the method of analysis and risk assessment in the marketing communication activity of pharmaceutical manufacturing enterprises in the promotion of a new medicine product using fuzzy modeling theory Fuzzy TECH. The developed mathematical model allows the subjects of the pharmaceutical market to reasonably and timely evaluate the impact of certain risk factors on the results of the marketing communications program's implementation when promoting a new medicine product under limiting and (or) saving investment funds for marketing communications. Taking into account the obtained results allows to make a managerial decision on choosing an optimal risk management strategy in marketing communication activities of enterprises: risk avoidance, risk transfer, risk reduction, risk taking. Conclusions. The given mathematical model is of practical value for the subjects of the pharmaceutical market, since it is not vulnerable to the number of input variables – higher or lower number of risk factors leads to higher or lower number of decision rules, with the model logic remaining unchanged
Authors and Affiliations
Anzhela Olkhovska, Volodymyr Malyi, Ihor Storozhenko
Keywords
Related Articles
- EP ID EP647958
- DOI 10.15587/2519-4852.2018.146479
- Views 169
- Downloads 0
Організація фармацевтичного забезпечення військовослужбовців, які брали участь у бойових діях, на засадах фармацевтичного права
<p>У статті наведено сучасний стан медико-фармацевтичного забезпечення пільгових категорій населення України, до яких чинним законодавством віднесено військовослужбовців, що брали участь у проведенні антитерористичної оп...
Збіжність результатів фармакопейних випробувань методами титрування: критерії прийнятності та експериментальні характеристики
<p>Забезпечення якості результатів випробувань є одним із актуальних питань діяльності контрольно-аналітичних лабораторій. За результатами попередніх досліджень авторами були розроблені науково обґрунтовані критерії та р...
Development and validation of HPLC/UV-procedures of secnidazole determination in blood and urine
<p><strong>Aim. </strong>The system of HPLC-analyzer MiLiChrome® A-02 is widely used in Ukrainian laboratories of forensic toxicology. The purpose is to apply the HPLC-analyzer system for secnidazole quantitative determi...
Sociometry as a method for assessing the socio-psychological climate in pharmacies
<p><strong>Aim. </strong>The aim of the study is to adapt the sociometric method of assessment of socio-psychological climate in the pharmacy due to questionnaire design, the construction of sociometric matrix and develo...
Study of superoxide- and NO-dependent protective mechanisms of N-acetylcysteine and losartan in ratʼs aorta and liver under streptozoticin-induced type 1 diabetes mellitus
<p><strong>Aim.</strong> The aim of the research was to investigate superoxide- (SR) and NO-dependent mechanisms of action of N-acetylcysteine (NAC) and losartan (LOS) in aorta and liver of rats with type 1 diabetes mell...